Diagenode
Provider of complete solutions for epigenetics research;biological sample PREparation;and diagnostics assays
Diagenode has raised €7.5M across 1 funding round from 3 investors, most recently a Early VC round in Jun 2016. Based in Liège, Belgium; founded 2003; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€7.5M
€7,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2016-06
latest 2016-06
Funding by year
EUR raised per yearDiagenode — funding by year — interactive chart.
Data table
| Diagenode — funding by year | |
|---|---|
| 2016 | €7.5M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-06-01 | Early VC | €7.5M | Capricorn Partners,Epimede,S.R.I.W - Societe Regionale d Investissement de Wallonie | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData